These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7540492)

  • 1. Audit of a screening service for fetal abnormalities using early ultrasound scanning and maternal serum alpha-fetoprotein estimation combined with selective detailed scanning.
    Chambers SE; Geirsson RT; Stewart RJ; Wannapirak C; Muir BB
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):168-73. PubMed ID: 7540492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound detection of fetal structural abnormalities in Auckland 1988-9.
    Roberts AB; Hampton E; Wilson N
    N Z Med J; 1993 Oct; 106(966):441-3. PubMed ID: 7694211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine prenatal ultrasound screening for fetal abnormalities: 22 years' experience.
    Carrera JM; Torrents M; Mortera C; Cusí V; Muñoz A
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):174-9. PubMed ID: 7788491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
    Papp Z; Tóth-Pál E; Papp C; Tóth Z; Szabó M; Veress L; Török O
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):320-6. PubMed ID: 8590201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
    Greene MF; Benacerraf BR
    Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prenatal diagnosis. Review, personal and prospective studies].
    Engel E; Empson J; DeLozier D; McGee B; da Costa Woodson E; Engel-de Montmollin M; Carter T; Lorber C; Cassidy SB; Millis J; Heller RM; Boehm F; Vanhooydonk J
    Schweiz Med Wochenschr; 1979 Jul; 109(27):998-1010. PubMed ID: 88763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries.
    Luck CA
    BMJ; 1992 Jun; 304(6840):1474-8. PubMed ID: 1611369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein.
    Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The facial profile in the diagnosis of fetal abnormalities.
    Turner GM; Twining P
    Clin Radiol; 1993 Jun; 47(6):389-95. PubMed ID: 8519144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A proposed protocol for obstetrical ultrasound examination].
    Novakov A; Vejnović T; Stojić S; Belopavlović Z
    Med Pregl; 1999; 52(9-10):351-6. PubMed ID: 10624383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein.
    Barth WH; Frigoletto FD; Krauss CM; MacMillin MD; Stryker JM; Benacerraf BR
    Obstet Gynecol; 1991 Jun; 77(6):897-900. PubMed ID: 1709481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period.
    Boyd PA; Rounding C; Chamberlain P; Wellesley D; Kurinczuk JJ
    BJOG; 2012 Aug; 119(9):1131-40. PubMed ID: 22676508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.